LFS. LFS (of N = 357) is stratified by (A) CCMUS; (B) PLT <100 × 109/L vs ≥100 × 109/L; (C) having <2 vs ≥2 mutations; (D) having a splicing pathway mutation; (E) Multivariable analysis including the variables of PLT <100 × 109/L vs ≥100 × 109/L and <2 vs ≥2 mutations (solid lines indicate having ≥2 mutations, dotted lines indicate mutation number <2, blue indicates PLTs of ≥100 × 109/L, and red indicates PLTs of <100 × 109/L); and (F) multivariable analysis including the variables of PLT count, having ≥2 mutations, and having a splicing pathway mutation (dotted lines indicate not having splicing mutations, solid lines indicate having splicing mutation, blue indicate PLTs of <100 × 109/L and MT <2, green indicate PLTs of <100 × 109/L and MT of ≥2, yellow indicate PLTs of ≥100 × 109/L and MT <2, and red indicate PLTs of ≥100 × 109/L and MT ≥2).

LFS. LFS (of N = 357) is stratified by (A) CCMUS; (B) PLT <100 × 109/L vs ≥100 × 109/L; (C) having <2 vs ≥2 mutations; (D) having a splicing pathway mutation; (E) Multivariable analysis including the variables of PLT <100 × 109/L vs ≥100 × 109/L and <2 vs ≥2 mutations (solid lines indicate having ≥2 mutations, dotted lines indicate mutation number <2, blue indicates PLTs of ≥100 × 109/L, and red indicates PLTs of <100 × 109/L); and (F) multivariable analysis including the variables of PLT count, having ≥2 mutations, and having a splicing pathway mutation (dotted lines indicate not having splicing mutations, solid lines indicate having splicing mutation, blue indicate PLTs of <100 × 109/L and MT <2, green indicate PLTs of <100 × 109/L and MT of ≥2, yellow indicate PLTs of ≥100 × 109/L and MT <2, and red indicate PLTs of ≥100 × 109/L and MT ≥2).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal